| Record Information |
| Version |
3.5 |
| Creation Date |
2006-08-13 04:27:48 -0600 |
| Update Date |
2013-05-29 13:39:34 -0600 |
| HMDB ID |
HMDB04080 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Anandamide |
| Description |
Anandamide is a highly potent endogenous agonist of the cannabinoid CB1 and CB2 receptors. CB1 receptors are predominantly found in the central nervous system (CNS) where they mainly mediate the psychotropic effects of Tetrahydrocannabinol (THC) and endocannabinoids, whereas the expression of the CB2 receptor is thought to be restricted to cells of the immune system. It was suggested that AEA might inhibit tumor cell proliferation or induce apoptosis independently of CB1 and CB2 receptors, via interaction with the type 1 vanilloid receptor (VR1). VR1 is an ion channel expressed almost exclusively by sensory neurons, activated by pH, noxious heat (>48 degree centigrade) and plant toxins and is thought to play an important role in nociception. Cervical cancer cells are sensitive to AEA-induced apoptosis via VR1 that is aberrantly expressed in vitro and in vivo while CB1 and CB2 receptors play a protective role. (PMID 15047233 ). Novel prostaglandins (prostaglandin glycerol esters and prostaglandin ethanolamides) are COX-2 oxidative metabolites of endogenous cannabinoids (such as Anandamide). Recent evidence suggests that these new types of prostaglandins are likely novel signaling mediators involved in synaptic transmission and plasticity. (PMID 16957004 ). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 5,8,11,14-Eicosatetraenoylethanolamide
- AEA
- Anandamide
- Anandamide (20.4, N-6)
- Anandamide(20:4, N-6)
- Arachidonic acid N-(hydroxyethyl)amide
- Arachidonylethanolamide
- N-(2-Hydroxyethyl)-5,8,11,14-Eicosatetraenamide (all-Z)
- N-(2-Hydroxyethyl)anachidonamide
- N-(5Z,8Z,11Z,14Z-Eicosatetraenoyl)-ethanolamine
- N-(5Z,8Z,11Z,14Z-Icosatetraenoyl)-ethanolamide
- N-Arachidonoyl ethanolamine
- N-Arachidonoyl-2-hydroxyethylamide
|
| Chemical Formula |
C22H37NO2 |
| Average Molecular Weight |
347.5347 |
| Monoisotopic Molecular Weight |
347.282429433 |
| IUPAC Name |
(5Z,8Z,11Z,14Z)-N-(2-hydroxyethyl)icosa-5,8,11,14-tetraenamide |
| Traditional IUPAC Name |
anandamide |
| CAS Registry Number |
94421-68-8 |
| SMILES |
CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO |
| InChI Identifier |
InChI=1S/C22H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)23-20-21-24/h6-7,9-10,12-13,15-16,24H,2-5,8,11,14,17-21H2,1H3,(H,23,25)/b7-6-,10-9-,13-12-,16-15- |
| InChI Key |
LGEQQWMQCRIYKG-DOFZRALJSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Lipids |
| Class |
Fatty Amides |
| Sub Class |
N-acyl Amines |
| Other Descriptors |
- Aliphatic Acyclic Compounds
- a monocarboxylic-acid-amide(Cyc)
- an <i>N</i>-acylethanolamine(Cyc)
|
| Substituents |
- Acyclic Alkene
- Carboxamide Group
- N Acylethanolamine
- Primary Alcohol
- Secondary Carboxylic Acid Amide
|
| Direct Parent |
N-acyl Amines |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Cell signaling
- Fuel and energy storage
- Fuel or energy source
- Membrane integrity/stability
|
| Application |
- Nutrients
- Stabilizers
- Surfactants and Emulsifiers
|
| Cellular locations |
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
Not Available |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
Not Available
|
| Biological Properties |
| Cellular Locations |
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
|
| Tissue Location |
Not Available
|
| Pathways |
Not Available
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.008 +/- 0.016 uM |
Adult (>18 years old) |
Both |
Normal
|
|
| Blood |
Detected and Quantified |
|
2.99 +/- 5.39 uM |
Adult (>18 years old) |
Both |
Normal
|
|
| Blood |
Detected and Quantified |
|
3.12 +/- 1.2 uM |
Adult (>18 years old) |
Not Specified |
Normal
|
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.01165 +/- 0.00753 uM |
Adult (>18 years old) |
Both |
Normal
|
|
|
| Abnormal Concentrations |
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.00255 +/- 0.00178 uM |
Adult (>18 years old) |
Both |
epileptic patients
|
|
|
| Associated Disorders and Diseases |
| Disease References |
None |
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
Not Available |
| DrugBank Metabolite ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB023303 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
4445241  |
| KEGG Compound ID |
C11695  |
| BioCyc ID |
CPD-7598  |
| BiGG ID |
Not Available |
| Wikipedia Link |
Anandamide  |
| NuGOwiki Link |
HMDB04080  |
| Metagene Link |
HMDB04080  |
| METLIN ID |
Not Available |
| PubChem Compound |
5281969  |
| PDB ID |
Not Available |
| ChEBI ID |
2700  |
| References |
| Synthesis Reference |
Qi, Longwu; Meijler, Michael M.; Lee, Sang-Hyeup; Sun, Chengzao; Janda, Kim D. Solid-Phase Synthesis of Anandamide Analogues. Organic Letters (2004), 6(10), 1673-1675. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Felder CC, Nielsen A, Briley EM, Palkovits M, Priller J, Axelrod J, Nguyen DN, Richardson JM, Riggin RM, Koppel GA, Paul SM, Becker GW: Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett. 1996 Sep 16;393(2-3):231-5.
Pubmed: 8814296
- Contassot E, Tenan M, Schnuriger V, Pelte MF, Dietrich PY: Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1. Gynecol Oncol. 2004 Apr;93(1):182-8.
Pubmed: 15047233
- Sang N, Chen C: Lipid signaling and synaptic plasticity. Neuroscientist. 2006 Oct;12(5):425-34.
Pubmed: 16957004
|